Oxygen-Enhanced MRI in HPV-Associated Oropharyngeal Cancer
Author Information
Author(s): Dubec Michael J., Price James, Berks Michael, Gaffney John, Little Ross A., Porta Nuria, Sridharan Nivetha, Datta Anubhav, McHugh Damien J., Hague Christina J., Cheung Susan, Manoharan Prakash, van Herk Marcel, Choudhury Ananya, Matthews Julian C., Parker Geoff J.M., Buckley David L., Harrington Kevin J., McPartlin Andrew, O’Connor James P.B.
Primary Institution: The Christie NHS Foundation Trust, Manchester, United Kingdom
Hypothesis
Can oxygen-enhanced MRI-derived hypoxic volume detect radiotherapy-induced hypoxia modification in HPV-associated oropharyngeal cancer?
Conclusion
Oxygen-enhanced MRI can detect early changes in hypoxia during radiotherapy, which may inform treatment strategies.
Supporting Evidence
- Oxygen-enhanced MRI identified hypoxia in all lesions.
- HVMRI reduced significantly from a median of 11.3 cm3 to 6.9 cm3 at week 2.
- 54.5% of lesions showed hypoxia reduction by week 2.
- 88.2% of lesions showed hypoxia reduction by week 4.
- Half of patients had discordant changes in primary and nodal tumors.
Takeaway
This study shows that a special type of MRI can help doctors see if cancer is getting less oxygen during treatment, which can help them decide how to treat it better.
Methodology
Patients underwent oxygen-enhanced MRI before and during radiotherapy to measure changes in hypoxic volume.
Potential Biases
Potential bias due to the exclusion of patients with p16-negative disease.
Limitations
Some patients had missing data due to scan cancellations and the study focused only on p16-positive patients.
Participant Demographics
Median age of participants was 67 years, with 21 males and 6 females.
Statistical Information
P-Value
<0.001
Confidence Interval
−45.7% to 84.1%
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website